Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort - Concepedia

Concepedia

Publication | Open Access

Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort

DOI Full Paper Access

17

Citations

20

References

2023

Year

Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx

United European Gastroenterology Journal

Abstract

Multiple successive switches from IFX originator to biosimilars are effective and safe in patients with IBD, irrespective of the number of IFX switches.

References

	Year	Citations

Page 1